Acinetobacter spp. | Other pathogensa | Total | |
---|---|---|---|
Number of patients (%) | 59 (42) | 82 (58) | 141 (100) |
Age | |||
Mean (SD) | 52 (18) | 56 (16) | 54 (17) |
Median (overall range) | 51 (17–92) | 57 (18–85) | 56 (17–92) |
Male sex (%) | 42 (71) | 45 (55) | 87 (62) |
APACHE II score | |||
Mean (SD) | 20 (7) | 20 (9) | 20 (8) |
Median (overall range) | 20 (7–40) | 19 (0–41) | 19 (0–41) |
CHARLSON score | |||
Mean (SD) | 3 (3) | 3 (3) | 3 (3) |
Median (overall range) | 2 (0–10) | 3 (0–11) | 3 (0–11) |
Co-morbid condition (%) | |||
Diabetes mellitus | 14 (24) | 17 (21) | 31 (22) |
Liver cirrhosis | 18 (31) | 10 (12) | 28 (20) |
Cancer | 12 (20) | 21 (26) | 33 (23) |
Solid organ transplant | 17 (29) | 13 (16) | 30 (21) |
Liver transplant | 14 (24) | 10 (12) | 24 (17) |
Kidney transplant | 3 (5) | 3 (4) | 6 (4) |
Hematopoietic cell transplant | 0 (0) | 2 (2) | 2 (1) |
HIV infection | 3 (5) | 6 (7) | 9 (6) |
Chronic renal disease | 15 (25) | 16 (20) | 31 (22) |
Obstructive pulmonar disease | 4 (7) | 8 (10) | 12 (9) |
Trauma | 8 (14) | 7 (9) | 15 (11) |
Systemic arterial hypertension | 19 (32) | 37 (45) | 56 (40) |
ICU length of stay previous to bacteremia (in days) | |||
Mean (SD) | 11 (14) | 17 (36) | 15 (29) |
Median (overall range) | 7 (2–82) | 9 (2–314) | 8 (2–314) |
Initial site of infection | |||
Bloodstream | 43 (73) | 58 (71) | 101 (72) |
Pneumonia | 3 (5) | 11 (13) | 14 (10) |
Surgical site | 5 (8) | 6 (7) | 11 (8) |
Urinary tract | 1 (2) | 2 (2) | 3 (2) |
Skin and soft tissue | 3 (5) | 0 (0) | 3 (2) |
Other | 4 (7) | 5 (7) | 9 (6) |